IIQ 1.67% 59.0¢ inoviq ltd

What a bode of confidence from the Nicoya CEO! Particularly the...

  1. 152 Posts.
    lightbulb Created with Sketch. 507
    What a bode of confidence from the Nicoya CEO! Particularly the last 3 words.

    Nicoya CEO and Founder Ryan Denomme said: “While Alto is a critical tool in drug development with its unprecedented sample throughput and automation capabilities, it’s also broadly applicable in many other impactful areas of disease research that align with our mission to improve human life.
    There is significant potential to leverage the Alto platform as a clinical diagnostic tool for many diseases, including cancer detection. We are excited to partner with INOVIQ in the development of this novel in‐vitro diagnostic test and bring together our unique technologies to commercialize this life‐changing innovation.”

    Good luck to all shareholders and hopefully sufferers in the not-too-distant future can have a fighting chance with this early detection.
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
(20min delay)
Last
59.0¢
Change
-0.010(1.67%)
Mkt cap ! $65.06M
Open High Low Value Volume
60.0¢ 60.0¢ 59.0¢ $17.47K 29.17K

Buyers (Bids)

No. Vol. Price($)
2 41547 58.5¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 13799 4
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
IIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.